rs4792008
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002470.4(MYH3):c.4956+32C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 1,604,222 control chromosomes in the GnomAD database, including 377,489 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.57 ( 27810 hom., cov: 33)
Exomes 𝑓: 0.69 ( 349679 hom. )
Consequence
MYH3
NM_002470.4 intron
NM_002470.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0540
Publications
9 publications found
Genes affected
MYH3 (HGNC:7573): (myosin heavy chain 3) Myosin is a major contractile protein which converts chemical energy into mechanical energy through the hydrolysis of ATP. Myosin is a hexameric protein composed of a pair of myosin heavy chains (MYH) and two pairs of nonidentical light chains. This gene is a member of the MYH family and encodes a protein with an IQ domain and a myosin head-like domain. Mutations in this gene have been associated with two congenital contracture (arthrogryposis) syndromes, Freeman-Sheldon syndrome and Sheldon-Hall syndrome. [provided by RefSeq, Jul 2008]
MYHAS (HGNC:50609): (myosin heavy chain gene cluster antisense RNA) Predicted to enable primary miRNA binding activity. Predicted to be involved in response to muscle activity and skeletal muscle fiber development. Predicted to act upstream of or within with a positive effect on gene expression. Predicted to be located in cytoplasm and nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 17-10632444-G-A is Benign according to our data. Variant chr17-10632444-G-A is described in ClinVar as Benign. ClinVar VariationId is 258690.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.728 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYH3 | ENST00000583535.6 | c.4956+32C>T | intron_variant | Intron 34 of 40 | 5 | NM_002470.4 | ENSP00000464317.1 | |||
| MYHAS | ENST00000579914.2 | n.705+18567G>A | intron_variant | Intron 4 of 4 | 4 | |||||
| MYHAS | ENST00000584139.2 | n.1041+18567G>A | intron_variant | Intron 7 of 8 | 3 | |||||
| MYHAS | ENST00000781814.1 | n.165-2241G>A | intron_variant | Intron 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.573 AC: 87100AN: 152014Hom.: 27808 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
87100
AN:
152014
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.607 AC: 148956AN: 245230 AF XY: 0.620 show subpopulations
GnomAD2 exomes
AF:
AC:
148956
AN:
245230
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.686 AC: 995503AN: 1452090Hom.: 349679 Cov.: 33 AF XY: 0.684 AC XY: 494676AN XY: 722910 show subpopulations
GnomAD4 exome
AF:
AC:
995503
AN:
1452090
Hom.:
Cov.:
33
AF XY:
AC XY:
494676
AN XY:
722910
show subpopulations
African (AFR)
AF:
AC:
9241
AN:
33372
American (AMR)
AF:
AC:
21435
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
18395
AN:
26112
East Asian (EAS)
AF:
AC:
14568
AN:
39682
South Asian (SAS)
AF:
AC:
46541
AN:
86142
European-Finnish (FIN)
AF:
AC:
34287
AN:
47664
Middle Eastern (MID)
AF:
AC:
2943
AN:
5224
European-Non Finnish (NFE)
AF:
AC:
808831
AN:
1109004
Other (OTH)
AF:
AC:
39262
AN:
60184
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
15752
31505
47257
63010
78762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19642
39284
58926
78568
98210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.573 AC: 87125AN: 152132Hom.: 27810 Cov.: 33 AF XY: 0.568 AC XY: 42234AN XY: 74356 show subpopulations
GnomAD4 genome
AF:
AC:
87125
AN:
152132
Hom.:
Cov.:
33
AF XY:
AC XY:
42234
AN XY:
74356
show subpopulations
African (AFR)
AF:
AC:
12254
AN:
41496
American (AMR)
AF:
AC:
8581
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
2442
AN:
3472
East Asian (EAS)
AF:
AC:
1917
AN:
5174
South Asian (SAS)
AF:
AC:
2524
AN:
4822
European-Finnish (FIN)
AF:
AC:
7470
AN:
10578
Middle Eastern (MID)
AF:
AC:
159
AN:
292
European-Non Finnish (NFE)
AF:
AC:
49855
AN:
67984
Other (OTH)
AF:
AC:
1245
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1638
3275
4913
6550
8188
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
724
1448
2172
2896
3620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1564
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Freeman-Sheldon syndrome Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Contractures, pterygia, and variable skeletal fusions syndrome 1B Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Arthrogryposis, distal, type 2B3 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Contractures, pterygia, and spondylocarpotarsal fusion syndrome 1A Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.